Alana Cheplowitz
Physician Assistant · Vernon Hills, ILNPI 1437616265
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (48.5%), speaking fees and consulting fees — rather than concentrated in one kind of arrangement. 29 manufacturers reported payments, led by Pfizer at 48.4% of the total. Reporting peaked in 2024 at $8,682 and has fallen 54.1% since, to $3,987 in 2025. Among physician assistant clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 461 payments — averaging $44.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$10K
- AbbVie$3K
- Biohaven Pharmaceuticals, Inc.$961
- Lilly USA, LLC$895
- Teva Pharmaceuticals USA, Inc.$846
- Lundbeck LLC$819
- plus $4K from 23 others
What the payments were for
- Consulting fees$3,02015%
- Speaking & faculty fees$5,92529%
- Travel & lodging$1,5117%
- Food & beverage$9,83748%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 41 | $9,827 |
| AbbVie(2 entities) | 102 | $3,261 |
| Biohaven Pharmaceuticals, Inc. | 10 | $961 |
| Lilly USA, LLC | 35 | $895 |
| Teva Pharmaceuticals USA, Inc. | 45 | $846 |
| Lundbeck LLC | 31 | $819 |
| Amgen | 28 | $627 |
| Upsher-smith Laboratories LLC | 25 | $416 |
| Impel Pharmaceuticals Inc. | 15 | $302 |
| Merck | 17 | $295 |
| Neurocrine Biosciences, Inc. | 12 | $254 |
| Biohaven Pharmaceutical Holding Company Ltd. | 11 | $199 |
| Impel Pharmaceuticals LLC | 9 | $194 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $176 |
| Eisai Inc. | 14 | $164 |
| Bausch Health US, LLC | 9 | $160 |
| Axsome Therapeutics, Inc. | 5 | $146 |
| Idorsia Pharmaceuticals US Inc | 7 | $112 |
| Otsuka America Pharmaceutical, Inc. | 6 | $101 |
| Tonix Medicines, Inc. | 5 | $100 |
| Currax Pharmaceuticals LLC | 6 | $91 |
| Supernus Pharmaceuticals, Inc. | 4 | $76 |
| Scilex Pharmaceuticals Inc. | 4 | $76 |
| Novartis | 3 | $60 |
| Amneal Pharmaceuticals LLC | 3 | $52 |
| Novo Nordisk | 1 | $24 |
| Johnson & Johnson | 1 | $24 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $22 |
| Almatica Pharma LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ZAVZPRET$7,619
- NURTEC ODT$2,480
- UBRELVY$663
- BOTOX$249
How this compares
$20,293 in reported general payments places this provider in the 95th percentile of 3,912 physician assistant providers in Illinois.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Nurtec OdtRimegepant Sulfate | 39 | $74,355 |
| UbrelvyUbrogepant | 25 | $30,852 |
| Emgality SyringeGalcanezumab-Gnlm | 11 | $20,762 |
| QuliptaAtogepant | 14 | $15,033 |
| Ajovy AutoinjectorFremanezumab-Vfrm | 13 | $13,507 |
| Emgality PenGalcanezumab-Gnlm | 14 | $12,879 |
| Diphenhydramine Hcl | 62 | $2,081 |
| Sumatriptan Succinate | 12 | $750 |
| Lacosamide | 24 | $666 |
| Chlorzoxazone | 14 | $551 |
| Ketorolac Tromethamine | 45 | $416 |
| Chlorpromazine Hcl | 12 | $314 |
| Olanzapine | 11 | $314 |
| Orphenadrine Citrate ErOrphenadrine Citrate | 13 | $270 |
| Memantine Hcl | 12 | $232 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerNurtec Odt | $9,827 | $74,35539 claims |
| AbbVieUbrelvy, Qulipta | $3,261 | $45,88539 claims |
| Lilly USA, LLCOlanzapine | $895 | $31411 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,912 physician assistant providers in Illinois.
Other physician assistant in Vernon Hills
- Andrew MastroChicago$419K
- Christopher AricoSkokie$407K
- Karlijn BurridgeWestmont$144K
- Ian MackeySkokie$135K
- Stephanie TraceyItasca$122K
- Olabimpe PhilipsAddison$103K
- Renata BlockChicago$103K
- Margaret RomanoChicago$82K
- Christina StarksChicago$77K
- Darrel CutlerHerrin$74K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.